GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $650,000 | -52.9% | 25,690 | -35.0% | 0.00% | -66.7% |
Q2 2021 | $1,381,000 | +18.7% | 39,535 | +39.2% | 0.00% | 0.0% |
Q1 2021 | $1,163,000 | -4.5% | 28,406 | +1.3% | 0.00% | 0.0% |
Q4 2020 | $1,218,000 | -58.1% | 28,039 | -46.8% | 0.00% | -62.5% |
Q3 2020 | $2,908,000 | -36.5% | 52,728 | -27.3% | 0.01% | -42.9% |
Q2 2020 | $4,576,000 | +55.6% | 72,479 | +25.8% | 0.01% | +27.3% |
Q1 2020 | $2,940,000 | +24.0% | 57,605 | +93.1% | 0.01% | +57.1% |
Q4 2019 | $2,371,000 | +85.2% | 29,827 | +25.6% | 0.01% | +75.0% |
Q2 2019 | $1,280,000 | +599.5% | 23,751 | +586.4% | 0.00% | +300.0% |
Q1 2019 | $183,000 | -35.1% | 3,460 | -53.4% | 0.00% | 0.0% |
Q4 2018 | $282,000 | 0.0% | 7,430 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $282,000 | -55.0% | 7,430 | -46.4% | 0.00% | -50.0% |
Q2 2018 | $626,000 | +4.9% | 13,850 | +12.1% | 0.00% | 0.0% |
Q1 2018 | $597,000 | – | 12,351 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |